{"url_path":"/sec/calc/8-k/2026-08-11/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1534133/0001193125-26-343428-index.html","accession_number":"0001193125-26-343428","cik":"0001534133","ticker":"CALC","issuer_name":"CalciMedica, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1534133/0001193125-26-343428-index.html","primary_entity_key":"0001534133","primary_entity_name":"CalciMedica, Inc."},"word_count":150,"has_tables":true,"body_markdown":"Item 2.02. Results of Operations and Financial Condition.\n\n \n\nOn August 11, 2026, CalciMedica, Inc. issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this report.\n\nThe information in this Item 2.02, including Exhibit 99.1 to this report, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by specific reference in such filing."}